# AnalytiCon Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/analyticon-discovery

- Industry: Biotechnology
- Headquarters: Potsdam, Germany
- Website: www.ac-discovery.com
- Total disclosed funding: $3M
- Latest round: Series C (Apr 28, 2005)
- Investors on record: 2

## About

AnalytiCon Discovery GmbH is a German company specializing in the research and development of natural products for pharmaceutical, cosmetic, and nutritional applications, providing innovative solutions to various market challenges.Founded in 2000 in Potsdam, Germany, AnalytiCon Discovery GmbH develops natural products targeting pharmaceutical, cosmetic, and nutritional applications. The company was acquired by BRAIN AG, part of MIG Fonds, in July 2014. The CEO is Lutz Müller-Kuhrt, who has a history of founding companies in the natural product sector. AnalytiCon Discovery has completed a total of 3 deals, with its most recent deal occurring on July 3, 2014, during which it raised USD 3.000 mn in a Series C funding round from investors including Berlin Capital Fund and Brandenburg Kapital.AnalytiCon Discovery specializes in the research and development of natural products, focusing on pharmaceutical, cosmetic, and nutritional applications. Their core offerings include comprehensive screening libraries that facilitate the discovery of novel compounds, aimed at addressing various health and wellness challenges. The company serves research institutions, pharmaceutical companies, and manufacturers in the cosmetic and nutritional sectors, enabling them to enhance their product lines. With a diverse client base across North America, Europe, and parts of Asia, AnalytiCon Discovery provides advanced natural resource technologies to meet industry demands for sustainable solutions.AnalytiCon Discovery generates revenue through a structured B2B model, focusing on partnerships and collaborations within the pharmaceutical, cosmetic, and nutritional industries. Revenue streams include fees for access to their screening libraries and potential royalties from products developed using their technologies. Their established relationships underscore the value of their proprietary products and services, although specific pricing details are not disclosed. The firm's approach emphasizes innovation and quality to meet the growing demand in their target sectors.AnalytiCon Discovery plans to enhance its product offerings and expand into new markets, specifically targeting regions in Asia and North America by 2025. The recent Series C funding round of USD 3.000 mn will facilitate these initiatives, allowing for the development of new products designed to address emerging health and wellness challenges. This strategic direction follows their acquisition by BRAIN AG in July 2014 and reflects a commitment to leveraging their expertise in natural products to drive growth.

## Funding rounds

- Series C, Apr 28, 2005, $3M — Berlin Capital Fund, Brandenburg Kapital

## Investors

- Berlin Capital Fund (https://capitalatlas.ai/funds/berlin-capital-fund) — Series C
- Brandenburg Kapital (https://capitalatlas.ai/funds/brandenburg-kapital) — Series C